S&P Futures
6,016.25 +29.25 (+0.49%) Dow Futures
44,680.00 +285.00 (+0.64%) Nasdaq Futures
20,967.50 +117.75 (+0.56%) Russell 2000 Futures
2,444.20 +30.60 (+1.27%) Crude Oil
70.90 -0.34 (-0.48%) Gold
2,675.10 -37.10 (-1.37%)
Innovent Biologics Inc. (IVBIY)
- PR Newswire
Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that nearly 10 accepted clinical data of its novel oncology molecules, including an oral presentation of updated Phase 1 result of its novel TOPO1i CLDN18.2 ADC (IBI343) in previously-treated pancreatic cancer, wil
- Simply Wall St.
High Growth Tech Stocks Leading The Future
In the wake of recent global market developments, U.S. stocks have rallied to record highs, driven by optimism around potential growth and tax reforms following a significant political shift. The small-cap Russell 2000 Index has notably surged, highlighting investor interest in high-growth opportunities within the tech sector. In such an environment, a strong stock is often characterized by robust earnings potential and innovative capabilities that can thrive amidst regulatory changes and...
